Singapore, Dec 9, 2021 - (ACN Newswire) - - Biolidics Limited ("Biolidics" or the "Company" and together with its subsidiaries, the "Group"), a medical technology company with a focus on innovative ...
The granting of emergency use authorization by the U.S. FDA to Roche AG for its four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and respiratory syncytial virus will allow the company ...
The global pandemic may be over, but SARS-CoV-2 continues to infect people around the world. Indeed, the United States has recorded roughly 750 deaths from COVID-19 over the past month. Now, an siRNA ...
Research reveals a sharp decline in both the effectiveness and duration of protection from prior infection post-Omicron, underscoring the need for updated vaccines to sustain immunity Study: ...
Used with the cobas ® 5800, 6800 and 8800 systems, cobas Respiratory 4-flex simultaneously detects and differentiates the four most common respiratory viruses, helping to ensure confidence in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results